" class="no-js "lang="en-US"> Jason Weidman - Medtech Alert
Sunday, February 05, 2023

Breaking News

Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials Trelleborg to Expand its BioPharmaceutical Manufacturing Footprint in Europe Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest enGene Appoints Alex Nichols, PhD as President and Chief Operating Officer Orexo Submits New Drug Application to FDA for OX124, a High-dose Rescue Medication for Opioid Overdose Abbott Announces US and European Approvals for New Technologies to Support Effective Treatment for Abnormal Heart Rhythms RefleXion Receives FDA Clearance for Biology-Guided Radiotherapy Treatment for Early and Late-stage Cancers Cardiff Oncology Announces the Appointment of Fairooz Kabbinavar, MD, FACP, as Chief Medical Officer
Jason Weidman

Jason Weidman

About Jason Weidman

Experienced medical device executive passionate about transforming healthcare, building great organizations, inspiring others, and developing people.

Related Story

Cardiovascular

 Robocath Completes First Robotic Angioplasties in Belgium | Pharmtech Focus

Medtronic Launches Newest-Generation Drug Coated Balloon Catheter in Europe for Treatment of Coronary Artery Disease

July 26 2021

Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the launch of the Prevail™ […]